stockrow
Friday 6 November 2026
Export IMVT’s income statement to Excel — free account
Immunovant, Inc.
IMVT Healthcare Biotechnology
- EPS
- −5.63%
- Free cash flow
- −5.96%
Quarter to June 2026, against a year earlier
30.53
2.14
+7.54%
Follow IMVT
Alert me
Immunovant, Inc. (IMVT) Book value per share
Immunovant, Inc.'s book value per share at the end of fiscal 2026 was 4.7×, unchanged from fiscal 2025. At the end of the quarter to 30 June 2026 it was 3.6×. Over the past ten years it has ranged from 0.0× (fiscal 2018) to 4.7× (fiscal 2026) — the current reading is the highest in ten years. Immunovant, Inc. ranks 189th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2026 | 4.7× | 0.14% |
| FY2025 | 4.7× | 4.34% |
| FY2024 | 4.5× | 51.88% |
| FY2023 | 2.9× | (31.24%) |
| FY2022 | 4.3× | (3.98%) |
| FY2021 | 4.5× | 104.86% |
| FY2020 | 2.2× | 557.89% |
| FY2019 | 0.3× | 19,370.59% |
| FY2018 | 0.0× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 3.6× | (23.45%) |
| Mar 2026 | 4.7× | (13.97%) |
| Dec 2025 | 5.4× | 81.53% |
| Sep 2025 | 3.0× | (15.96%) |
| 27 more quarters | Free account |
Against its own ten years
Low 0.0×
High 4.7×
Ten-year median
4.3×
Current reading's percentile
100
Book value per share against peers
| Company | Book value per share |
|---|---|
| LGND Ligand Pharmaceuticals Incorporated compare | 48.2× |
| MANE Veradermics Incorporated compare | 20.1× |
| BLTE Belite Bio, Inc. Sponsored ADR compare | 19.3× |
| CGON CG Oncology, Inc. compare | 11.7× |
| IMVT Immunovant, Inc. | 3.6× |
| IONS Ionis Pharmaceuticals, Inc. compare | 2.7× |
| KOD Kodiak Sciences Inc. compare | 1.0× |
| MIRM Mirum Pharmaceuticals, Inc. compare | −0.8× |
| PTCT PTC Therapeutics, Inc. compare | −2.3× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))